COVID-19 Vaccine Portfolio

COVID-19 vaccine combinations under development are in 4 technical routes, which can cover numerous variants, and improve the success rate. Meanwhile, they are also provided with flexible sequential regimen. Such vaccine combinations include the 1st and 2nd generations of mRNA COVID-19 vaccine under development, Second Generation Inactivated COVID-19 Vaccine Against Delta Variant Strain under development, Recombinant Nanoparticle Protein COVID-19 Vaccine under development and broad-spectrum COVID-19 vaccine that is under development based on adenovirus vectors. All optional COVID-19 vaccine products are targeted at Delta variant.